S Zhong1, W Chen2, X Yu3, Z Chen4, Q Hu5, J Zhao1. 1. Center of Clinical Laboratory Science, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Nanjing, China. 2. The Fourth Clinical College of Nanjing Medical University, Nanjing, China. 3. Department of Hematology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, China. 4. Department of General Surgery, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, China. 5. Teaching and Research Office of General Surgery, Xuzhou Medical College, Xuzhou, China.
Abstract
BACKGROUND/ OBJECTIVES: Epidemiologic findings concerning the association between coffee consumption and prostate cancer risk yielded mixed results. We aimed to investigate the association by performing a meta-analysis of all available studies. SUBJECTS/ METHODS: We searched PubMed, Web of Science and EMBASE for studies published up to July 2013. We calculated the summary relative risk (RR) and 95% confidence intervals (CIs) for ever, moderate and highest consumption of coffee vs non/lowest consumption. The dose-response relationship was assessed by restricted cubic spline model and multivariate random-effect meta-regression. RESULTS: A total of 12 case-control studies and 12 cohort studies with 42,179 cases were selected for final meta-analysis. No significant associations were found among overall analysis. A borderline positive association was found for highest drinkers in five small hospital-based case-control (HCC) studies involving 2278 cases. However, compared with non/lowest drinkers, the summary RRs were 0.92 (95% CI=0.85-0.99) for ever drinkers, 0.92 (95% CI=0.85-1.00) for moderate drinkers and 0.83 (95% CI=0.72-0.96) for highest drinkers from 12 cohort studies, comprising a total of 34,424 cases. An increase in coffee intake of two cups/day was associated with a 7% decreased risk of prostate cancer according to cohort studies. A significant inverse relationship was also found for fatal prostate cancers and high-grade prostate cancers. CONCLUSIONS: Case-control studies especially HCC ones might be prone to selection bias and recall bias that might have contributed to the conflicting results. Therefore, the present meta-analysis suggests a borderline significant inverse association between coffee consumption and prostate cancer risk based on cohort studies.
BACKGROUND/ OBJECTIVES: Epidemiologic findings concerning the association between coffee consumption and prostate cancer risk yielded mixed results. We aimed to investigate the association by performing a meta-analysis of all available studies. SUBJECTS/ METHODS: We searched PubMed, Web of Science and EMBASE for studies published up to July 2013. We calculated the summary relative risk (RR) and 95% confidence intervals (CIs) for ever, moderate and highest consumption of coffee vs non/lowest consumption. The dose-response relationship was assessed by restricted cubic spline model and multivariate random-effect meta-regression. RESULTS: A total of 12 case-control studies and 12 cohort studies with 42,179 cases were selected for final meta-analysis. No significant associations were found among overall analysis. A borderline positive association was found for highest drinkers in five small hospital-based case-control (HCC) studies involving 2278 cases. However, compared with non/lowest drinkers, the summary RRs were 0.92 (95% CI=0.85-0.99) for ever drinkers, 0.92 (95% CI=0.85-1.00) for moderate drinkers and 0.83 (95% CI=0.72-0.96) for highest drinkers from 12 cohort studies, comprising a total of 34,424 cases. An increase in coffee intake of two cups/day was associated with a 7% decreased risk of prostate cancer according to cohort studies. A significant inverse relationship was also found for fatal prostate cancers and high-grade prostate cancers. CONCLUSIONS: Case-control studies especially HCC ones might be prone to selection bias and recall bias that might have contributed to the conflicting results. Therefore, the present meta-analysis suggests a borderline significant inverse association between coffee consumption and prostate cancer risk based on cohort studies.
Authors: A W Hsing; J K McLaughlin; L M Schuman; E Bjelke; G Gridley; S Wacholder; H T Chien; W J Blot Journal: Cancer Res Date: 1990-11-01 Impact factor: 12.701
Authors: Milan S Geybels; Marian L Neuhouser; Jonathan L Wright; Marni Stott-Miller; Janet L Stanford Journal: Cancer Causes Control Date: 2013-08-02 Impact factor: 2.506
Authors: Hugo Deneo-Pellegrini; Alvaro L Ronco; Eduardo De Stefani; Paolo Boffetta; Pelayo Correa; María Mendilaharsu; Gisele Acosta Journal: Cancer Causes Control Date: 2012-04-28 Impact factor: 2.506
Authors: Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J Vatten; Jeff M P Holly; Richard M Martin Journal: Int J Cancer Date: 2009-05-15 Impact factor: 7.396
Authors: Mia Hashibe; Carlotta Galeone; Saundra S Buys; Lisa Gren; Paolo Boffetta; Zuo-Feng Zhang; Carlo La Vecchia Journal: Br J Cancer Date: 2015-08-20 Impact factor: 7.640
Authors: Kjell M Russnes; Elisabeth Möller; Kathryn M Wilson; Monica Carlsen; Rune Blomhoff; Sigbjørn Smeland; Hans-Olov Adami; Henrik Grönberg; Lorelei A Mucci; Katarina Bälter Journal: BMC Cancer Date: 2016-07-11 Impact factor: 4.430